ํBVF โข FRA
add
๋ฐธ๋ฆฌ์ธํธ์ ์ฝ
์ ์ผ ์ข
๊ฐ
โฌ4.59
์ผ์ผ ๋ณ๋ํญ
โฌ4.68 - โฌ4.68
52์ฃผ ๋ณ๋ํญ
โฌ3.83 - โฌ7.00
์๊ฐ์ด์ก
21.96์ต USD
ํ๊ท ๊ฑฐ๋๋
42.00
์ฃผ๊ฐ์์ต๋ฅ
-
๋ฐฐ๋น์์ต๋ฅ
-
๋ด์ค
์ฌ๋ฌด
์์ต๊ณ์ฐ์
์์ต
์์ด์ต
| (USD) | 2025๋ 12์info | ์ ๋ ๋๋น ๋ณ๋ |
|---|---|---|
์์ต | 27.96์ต | 9.26% |
์ด์๋น | 12.77์ต | 3.40% |
์์ด์ต | -1.12์ต | -220.43% |
์์ด์ต๋ฅ | -4.01 | -210.47% |
์ฃผ๋น ์์ต | 1.10 | -5.09% |
EBITDA | 10.11์ต | 11.84% |
์ ํจ ์ธ์จ | 283.93% | โ |
๋์ฐจ๋์กฐํ
์ด์์ฐ
์ด๋ถ์ฑ
| (USD) | 2025๋ 12์info | ์ ๋ ๋๋น ๋ณ๋ |
|---|---|---|
ํ๊ธ ๋ฐ ๋จ๊ธฐ ํฌ์ | 13.09์ต | 10.84% |
์ด์์ฐ | 263.66์ต | -0.59% |
์ด๋ถ์ฑ | 259.89์ต | -3.19% |
์ด์๊ธฐ์๋ณธ | 3.77์ต | โ |
๋ฐํ ์ฃผ์ | 3.71์ต | โ |
์ฃผ๊ฐ์์์ฐ๋น์จ | -3.06 | โ |
์ด์์ฐ์ด์ต๋ฅ | 6.78% | โ |
์๋ณธ์ด์ต๋ฅ | 8.41% | โ |
ํ๊ธ ํ๋ฆ
์ํ๊ธํ๋ฆ
| (USD) | 2025๋ 12์info | ์ ๋ ๋๋น ๋ณ๋ |
|---|---|---|
์์ด์ต | -1.12์ต | -220.43% |
์์
ํ๊ธ ํ๋ฆ | 4.95์ต | -17.64% |
ํฌ์ ํ๊ธ ํ๋ฆ | -2.82์ต | -41.00% |
์๊ธ ์กฐ๋ฌ ํ๊ธ ํ๋ฆ | -2.35์ต | -376.47% |
์ํ๊ธํ๋ฆ | -1500.00๋ง | -103.33% |
์์ฌ ํ๊ธ ํ๋ฆ | 2.06์ต | -43.35% |
์ ๋ณด
Bausch Health Companies Inc. is an American-Canadian pharmaceutical company. Its global corporate headquarters are located in Laval, Quebec, Canada, and its U.S. headquarters are in Bridgewater, New Jersey. It develops, manufactures and markets a range of pharmaceutical products in gastroenterology, hepatology, neuroscience, dermatology, dentistry, medical aesthetics, and international pharmaceuticals.
Bausch Health manufactures and markets branded pharmaceuticals, generic pharmaceuticals, and over-the-counter products directly or indirectly in more than 90 countries and regions, including the United States, Canada, Europe, the Middle East, Africa, Asia Pacific and Latin America. Wikipedia
CEO
์ค๋ฆฝ
1959
๋ณธ์ฌ
์น์ฌ์ดํธ
์ง์ ์
20,300